1T1F - JenaLib

Asym.Unit - manually (Jmol Viewer)

Asymmetric Unit (Jmol Viewer)

Asym. Unit - sites (Jmol Viewer)

Biological Unit 1 (Jmol Viewer)

Biol. Unit 1 - sites (Jmol Viewer)

Biological Unit 2 (Jmol Viewer)

Biological Unit 3 (Jmol Viewer)

Title :   CRYSTAL STRUCTURE OF NATIVE ANTITHROMBIN IN ITS MONOMERIC FORM

Authors :   D. J. D. Johnson, J. A. Huntington

Date :   16 Apr 04 (Deposition) - 04 Oct 05 (Release) - 13 Jul 11 (Revision)

Method :   X-RAY DIFFRACTION

Resolution :   2.75

Chains :   Asym. Unit : A,B,C
Biol. Unit 1: A  (1x)
Biol. Unit 2: B  (1x)
Biol. Unit 3: C  (1x)

Keywords :   Serine-Cysteine Proteinase Inhibitor; Thrombin; Human; X-Ray Crystallography, Blood Clotting (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   D. J. D. Johnson, J. Langdown, W. Li, S. A. Luis, T. P. Baglin, J. A. Huntington
Crystal Structure Of Monomeric Native Antithrombin Reveals Novel Reactive Center Loop Conformation
J. Biol. Chem. V. 281 35478 2006
PubMed-ID: 16973611 | Reference-DOI: 10.1074/JBC.M607204200

Molecule 1 - ANTITHROMBIN-III
	Chains	:	A, B, C
	Engineered	:	YES
	Expression System	:	CRICETULUS GRISEUS
	Expression System Cell	:	BABY HAMPSTER KIDNEY CELLS
	Expression System Common	:	CHINESE HAMSTER
	Expression System Plasmid	:	PMASTOP
	Expression System Taxid	:	10029
	Expression System Vector Type	:	PLASMID
	Gene	:	SERPINC1
	Mutation	:	YES
	Organ	:	BLOOD
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	ATIII; PRO0309
	Tissue	:	PLASMA

		1	2	3
Asymmetric Unit	:	A	B	C
Biological Unit 1 (1x)	:	A
Biological Unit 2 (1x)	:		B
Biological Unit 3 (1x)	:			C

Summary Information (see also Sequences/Alignments below)

Asymmetric Unit (4, 45)

No.	Name	Count	Type	Full Name
1	BMA	3	Ligand/Ion	BETA-D-MANNOSE
2	GOL	3	Ligand/Ion	GLYCEROL
3	IOD	21	Ligand/Ion	IODIDE ION
4	NAG	18	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE

Biological Unit 1 (4, 15)

No.	Name	Count	Type	Full Name
1	BMA	1	Ligand/Ion	BETA-D-MANNOSE
2	GOL	1	Ligand/Ion	GLYCEROL
3	IOD	7	Ligand/Ion	IODIDE ION
4	NAG	6	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE

Biological Unit 2 (4, 15)

No.	Name	Count	Type	Full Name
1	BMA	1	Ligand/Ion	BETA-D-MANNOSE
2	GOL	1	Ligand/Ion	GLYCEROL
3	IOD	7	Ligand/Ion	IODIDE ION
4	NAG	6	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE

Biological Unit 3 (4, 15)

No.	Name	Count	Type	Full Name
1	BMA	1	Ligand/Ion	BETA-D-MANNOSE
2	GOL	1	Ligand/Ion	GLYCEROL
3	IOD	7	Ligand/Ion	IODIDE ION
4	NAG	6	Ligand/Ion	N-ACETYL-D-GLUCOSAMINE

Asymmetric Unit (39, 39)

No.	Name	Evidence	Residues	Description
01	AC1	SOFTWARE	ASN A:96 , LYS A:350 , NAG A:802 , HOH A:2012	BINDING SITE FOR RESIDUE NAG A 801
02	AC2	SOFTWARE	NAG A:801	BINDING SITE FOR RESIDUE NAG A 802
03	AC3	SOFTWARE	ASN A:18 , MET A:20 , ASN A:155 , THR A:157 , NAG A:842	BINDING SITE FOR RESIDUE NAG A 841
04	AC4	SOFTWARE	ASN A:18 , MET A:20 , NAG A:841 , BMA A:843	BINDING SITE FOR RESIDUE NAG A 842
05	AC5	SOFTWARE	ILE A:22 , NAG A:842	BINDING SITE FOR RESIDUE BMA A 843
06	AC6	SOFTWARE	LYS A:188 , ASN A:192 , NAG A:862	BINDING SITE FOR RESIDUE NAG A 861
07	AC7	SOFTWARE	NAG A:861	BINDING SITE FOR RESIDUE NAG A 862
08	AC8	SOFTWARE	ASN B:96 , LYS B:350 , NAG B:802 , HOH B:2019	BINDING SITE FOR RESIDUE NAG B 801
09	AC9	SOFTWARE	NAG B:801	BINDING SITE FOR RESIDUE NAG B 802
10	BC1	SOFTWARE	ASN B:18 , MET B:20 , ASN B:155 , THR B:157 , NAG B:842	BINDING SITE FOR RESIDUE NAG B 841
11	BC2	SOFTWARE	ASN B:18 , MET B:20 , NAG B:841 , BMA B:843	BINDING SITE FOR RESIDUE NAG B 842
12	BC3	SOFTWARE	ILE B:22 , NAG B:842	BINDING SITE FOR RESIDUE BMA B 843
13	BC4	SOFTWARE	LYS B:188 , ASN B:192 , NAG B:862	BINDING SITE FOR RESIDUE NAG B 861
14	BC5	SOFTWARE	NAG B:861	BINDING SITE FOR RESIDUE NAG B 862
15	BC6	SOFTWARE	ASN C:96 , LYS C:350 , NAG C:802 , HOH C:2028	BINDING SITE FOR RESIDUE NAG C 801
16	BC7	SOFTWARE	NAG C:801	BINDING SITE FOR RESIDUE NAG C 802
17	BC8	SOFTWARE	ASN C:18 , MET C:20 , ASN C:155 , THR C:157 , NAG C:842	BINDING SITE FOR RESIDUE NAG C 841
18	BC9	SOFTWARE	ASN C:18 , MET C:20 , NAG C:841 , BMA C:843	BINDING SITE FOR RESIDUE NAG C 842
19	CC1	SOFTWARE	ILE C:22 , NAG C:842	BINDING SITE FOR RESIDUE BMA C 843
20	CC2	SOFTWARE	LYS C:188 , ASN C:192 , NAG C:862	BINDING SITE FOR RESIDUE NAG C 861
21	CC3	SOFTWARE	NAG C:861	BINDING SITE FOR RESIDUE NAG C 862
22	CC4	SOFTWARE	GLU A:42	BINDING SITE FOR RESIDUE IOD A 2002
23	CC5	SOFTWARE	GLU A:255	BINDING SITE FOR RESIDUE IOD A 2004
24	CC6	SOFTWARE	LEU A:395	BINDING SITE FOR RESIDUE IOD A 2005
25	CC7	SOFTWARE	SER A:191 , THR A:199 , ASP A:200	BINDING SITE FOR RESIDUE IOD A 2006
26	CC8	SOFTWARE	LYS A:70 , ASP A:327	BINDING SITE FOR RESIDUE IOD A 2007
27	CC9	SOFTWARE	GLU B:42	BINDING SITE FOR RESIDUE IOD B 2009
28	DC1	SOFTWARE	GLU B:255	BINDING SITE FOR RESIDUE IOD B 2011
29	DC2	SOFTWARE	LEU B:395	BINDING SITE FOR RESIDUE IOD B 2012
30	DC3	SOFTWARE	SER B:191 , THR B:199 , ASP B:200	BINDING SITE FOR RESIDUE IOD B 2013
31	DC4	SOFTWARE	LYS B:70 , ASP B:327	BINDING SITE FOR RESIDUE IOD B 2014
32	DC5	SOFTWARE	GLU C:42	BINDING SITE FOR RESIDUE IOD C 2016
33	DC6	SOFTWARE	GLU C:255	BINDING SITE FOR RESIDUE IOD C 2018
34	DC7	SOFTWARE	LEU C:395	BINDING SITE FOR RESIDUE IOD C 2019
35	DC8	SOFTWARE	SER C:191 , THR C:199 , ASP C:200	BINDING SITE FOR RESIDUE IOD C 2020
36	DC9	SOFTWARE	LYS C:70 , ASP C:327	BINDING SITE FOR RESIDUE IOD C 2021
37	EC1	SOFTWARE	LYS A:70 , ASP A:327 , PHE A:329 , SER A:330 , HOH A:2076	BINDING SITE FOR RESIDUE GOL A 1001
38	EC2	SOFTWARE	LYS B:70 , ASP B:327 , PHE B:329 , SER B:330 , HOH B:2085	BINDING SITE FOR RESIDUE GOL B 1002
39	EC3	SOFTWARE	LYS C:70 , ASP C:327 , PHE C:329 , SER C:330 , HOH C:2094	BINDING SITE FOR RESIDUE GOL C 1003

Asymmetric Unit

No.	Residues
1	A:8	-	A:128
2	A:21	-	A:95
3	A:247	-	A:430
4	A:317	-	A:401
5	B:8	-	B:128
6	B:21	-	B:95
7	B:247	-	B:430
8	B:317	-	B:401
9	C:8	-	C:128
10	C:21	-	C:95
11	C:247	-	C:430
12	C:317	-	C:401

(no "Cis Peptide Bond" information available for 1T1F)

Asymmetric Unit (86, 258)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_007033	I	39	N	ANT3_HUMAN	Disease (AT3D)	28929468	A/B/C	I	7	N
02	UniProt	VAR_007034	M	52	T	ANT3_HUMAN	Unclassified	---	A/B/C	M	20	T
03	UniProt	VAR_071199	C	53	F	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	C	21	F
04	UniProt	VAR_007035	R	56	C	ANT3_HUMAN	Disease (AT3D)	28929469	A/B/C	R	24	C
05	UniProt	VAR_007036	P	73	L	ANT3_HUMAN	Disease (AT3D)	121909551	A/B/C	P	41	L
06	UniProt	VAR_007037	R	79	C	ANT3_HUMAN	Disease (AT3D)	121909547	A/B/C	R	47	C
07	UniProt	VAR_007038	R	79	H	ANT3_HUMAN	Disease (AT3D)	121909552	A/B/C	R	47	H
08	UniProt	VAR_007039	R	79	S	ANT3_HUMAN	Disease (AT3D)	121909547	A/B/C	R	47	S
09	UniProt	VAR_007041	R	89	C	ANT3_HUMAN	Disease (AT3D)	147266200	A/B/C	R	57	C
10	UniProt	VAR_007042	F	90	L	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	F	58	L
11	UniProt	VAR_027452	Y	95	C	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	Y	63	C
12	UniProt	VAR_012316	Y	95	S	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	Y	63	S
13	UniProt	VAR_027453	L	98	P	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	L	66	P
14	UniProt	VAR_007044	P	112	T	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	P	80	T
15	UniProt	VAR_027454	M	121	K	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	M	89	K
16	UniProt	VAR_071200	G	125	D	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	G	93	D
17	UniProt	VAR_027455	C	127	R	ANT3_HUMAN	Disease (AT3D)	121909573	A/B/C	C	95	R
18	UniProt	VAR_007045	L	131	F	ANT3_HUMAN	Disease (AT3D)	121909567	A/B/C	L	99	F
19	UniProt	VAR_007046	L	131	V	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	L	99	V
20	UniProt	VAR_007047	Q	133	K	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	Q	101	K
21	UniProt	VAR_027456	K	146	E	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	K	114	E
22	UniProt	VAR_013085	T	147	A	ANT3_HUMAN	Polymorphism	2227606	A/B/C	T	115	A
23	UniProt	VAR_007049	S	148	P	ANT3_HUMAN	Disease (AT3D)	121909569	A/B/C	S	116	P
24	UniProt	VAR_007050	Q	150	P	ANT3_HUMAN	Disease (AT3D)	765445413	A/B/C	Q	118	P
25	UniProt	VAR_007051	H	152	Y	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	H	120	Y
26	UniProt	VAR_007053	L	158	P	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	L	126	P
27	UniProt	VAR_027457	C	160	Y	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	C	128	Y
28	UniProt	VAR_007054	R	161	Q	ANT3_HUMAN	Disease (AT3D)	121909563	A/B/C	R	129	Q
29	UniProt	VAR_012750	N	167	T	ANT3_HUMAN	Polymorphism	121909570	A/B/C	N	135	T
30	UniProt	VAR_071201	S	170	P	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	S	138	P
31	UniProt	VAR_027458	L	178	H	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	L	146	H
32	UniProt	VAR_027459	F	179	L	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	F	147	L
33	UniProt	VAR_007055	Y	190	C	ANT3_HUMAN	Polymorphism	---	A/B/C	Y	158	C
34	UniProt	VAR_007056	Y	198	C	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	Y	166	C
35	UniProt	VAR_027460	Y	198	H	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	Y	166	H
36	UniProt	VAR_027461	S	214	F	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	S	182	F
37	UniProt	VAR_007057	S	214	Y	ANT3_HUMAN	Disease (AT3D)	483352854	A/B/C	S	182	Y
38	UniProt	VAR_071202	I	218	N	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	I	186	N
39	UniProt	VAR_007059	N	219	D	ANT3_HUMAN	Disease (AT3D)	121909571	A/B/C	N	187	D
40	UniProt	VAR_007058	N	219	K	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	N	187	K
41	UniProt	VAR_027463	S	223	P	ANT3_HUMAN	Disease (AT3D)	121909572	A/B/C	S	191	P
42	UniProt	VAR_027464	T	243	I	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	T	211	I
43	UniProt	VAR_071203	V	248	G	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	V	216	G
44	UniProt	VAR_027465	I	251	T	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	I	219	T
45	UniProt	VAR_027466	W	257	R	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	W	225	R
46	UniProt	VAR_027467	F	261	L	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	F	229	L
47	UniProt	VAR_007060	E	269	K	ANT3_HUMAN	Disease (AT3D)	758087836	A/B/C	E	237	K
48	UniProt	VAR_007062	M	283	I	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	M	251	I
49	UniProt	VAR_027468	M	283	V	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	M	251	V
50	UniProt	VAR_071204	R	293	P	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	R	261	P
51	UniProt	VAR_007063	L	302	P	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	L	270	P
52	UniProt	VAR_007064	I	316	N	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	I	284	N
53	UniProt	VAR_027469	S	323	P	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	S	291	P
54	UniProt	VAR_007065	E	334	K	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	E	302	K
55	UniProt	VAR_007067	S	381	P	ANT3_HUMAN	Disease (AT3D)	121909565	A/B/C	S	349	P
56	UniProt	VAR_007068	R	391	Q	ANT3_HUMAN	Polymorphism	201541724	A/B/C	R	359	Q
57	UniProt	VAR_027470	S	397	P	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	S	365	P
58	UniProt	VAR_027471	D	398	H	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	D	366	H
59	UniProt	VAR_071205	H	401	R	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	H	369	R
60	UniProt	VAR_027472	S	412	R	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	S	380	R
61	UniProt	VAR_007069	A	414	T	ANT3_HUMAN	Disease (AT3D)	121909557	A/B/C	A	382	T
62	UniProt	VAR_007070	A	416	P	ANT3_HUMAN	Disease (AT3D)	28930978	A/B/C	A	384	P
63	UniProt	VAR_007071	A	416	S	ANT3_HUMAN	Disease (AT3D)	121909548	A/B/C	A	384	S
64	UniProt	VAR_007072	A	419	V	ANT3_HUMAN	Disease (AT3D)	121909568	A/B/C	A	387	V
65	UniProt	VAR_007073	G	424	D	ANT3_HUMAN	Disease (AT3D)	121909566	A/B/C	G	392	D
66	UniProt	VAR_007075	R	425	C	ANT3_HUMAN	Disease (AT3D)	121909554	A/B/C	R	393	C
67	UniProt	VAR_007074	R	425	H	ANT3_HUMAN	Disease (AT3D)	121909549	A/B/C	R	393	H
68	UniProt	VAR_007076	R	425	P	ANT3_HUMAN	Disease (AT3D)	121909549	A/B/C	R	393	P
69	UniProt	VAR_007077	S	426	L	ANT3_HUMAN	Disease (AT3D)	121909550	A/B/C	S	394	L
70	UniProt	VAR_007078	F	434	C	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	F	402	C
71	UniProt	VAR_007080	F	434	L	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	F	402	L
72	UniProt	VAR_007079	F	434	S	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	F	402	S
73	UniProt	VAR_007081	A	436	T	ANT3_HUMAN	Disease (AT3D)	121909546	A/B/C	A	404	T
74	UniProt	VAR_007082	N	437	K	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	N	405	K
75	UniProt	VAR_009258	R	438	G	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	R	406	G
76	UniProt	VAR_007083	R	438	M	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	R	406	M
77	UniProt	VAR_071206	P	439	A	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	P	407	A
78	UniProt	VAR_007084	P	439	L	ANT3_HUMAN	Disease (AT3D)	121909555	A/B/C	P	407	L
79	UniProt	VAR_007085	P	439	T	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	P	407	T
80	UniProt	VAR_027473	L	441	P	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	L	409	P
81	UniProt	VAR_007086	I	453	T	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	I	421	T
82	UniProt	VAR_007087	G	456	R	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	G	424	R
83	UniProt	VAR_007088	R	457	T	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	R	425	T
84	UniProt	VAR_007090	A	459	D	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	A	427	D
85	UniProt	VAR_007091	P	461	L	ANT3_HUMAN	Disease (AT3D)	121909564	A/B/C	P	429	L
86	UniProt	VAR_007092	C	462	F	ANT3_HUMAN	Disease (AT3D)	---	A/B/C	C	430	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 1 (86, 86)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_007033	I	39	N	ANT3_HUMAN	Disease (AT3D)	28929468	A	I	7	N
02	UniProt	VAR_007034	M	52	T	ANT3_HUMAN	Unclassified	---	A	M	20	T
03	UniProt	VAR_071199	C	53	F	ANT3_HUMAN	Disease (AT3D)	---	A	C	21	F
04	UniProt	VAR_007035	R	56	C	ANT3_HUMAN	Disease (AT3D)	28929469	A	R	24	C
05	UniProt	VAR_007036	P	73	L	ANT3_HUMAN	Disease (AT3D)	121909551	A	P	41	L
06	UniProt	VAR_007037	R	79	C	ANT3_HUMAN	Disease (AT3D)	121909547	A	R	47	C
07	UniProt	VAR_007038	R	79	H	ANT3_HUMAN	Disease (AT3D)	121909552	A	R	47	H
08	UniProt	VAR_007039	R	79	S	ANT3_HUMAN	Disease (AT3D)	121909547	A	R	47	S
09	UniProt	VAR_007041	R	89	C	ANT3_HUMAN	Disease (AT3D)	147266200	A	R	57	C
10	UniProt	VAR_007042	F	90	L	ANT3_HUMAN	Disease (AT3D)	---	A	F	58	L
11	UniProt	VAR_027452	Y	95	C	ANT3_HUMAN	Disease (AT3D)	---	A	Y	63	C
12	UniProt	VAR_012316	Y	95	S	ANT3_HUMAN	Disease (AT3D)	---	A	Y	63	S
13	UniProt	VAR_027453	L	98	P	ANT3_HUMAN	Disease (AT3D)	---	A	L	66	P
14	UniProt	VAR_007044	P	112	T	ANT3_HUMAN	Disease (AT3D)	---	A	P	80	T
15	UniProt	VAR_027454	M	121	K	ANT3_HUMAN	Disease (AT3D)	---	A	M	89	K
16	UniProt	VAR_071200	G	125	D	ANT3_HUMAN	Disease (AT3D)	---	A	G	93	D
17	UniProt	VAR_027455	C	127	R	ANT3_HUMAN	Disease (AT3D)	121909573	A	C	95	R
18	UniProt	VAR_007045	L	131	F	ANT3_HUMAN	Disease (AT3D)	121909567	A	L	99	F
19	UniProt	VAR_007046	L	131	V	ANT3_HUMAN	Disease (AT3D)	---	A	L	99	V
20	UniProt	VAR_007047	Q	133	K	ANT3_HUMAN	Disease (AT3D)	---	A	Q	101	K
21	UniProt	VAR_027456	K	146	E	ANT3_HUMAN	Disease (AT3D)	---	A	K	114	E
22	UniProt	VAR_013085	T	147	A	ANT3_HUMAN	Polymorphism	2227606	A	T	115	A
23	UniProt	VAR_007049	S	148	P	ANT3_HUMAN	Disease (AT3D)	121909569	A	S	116	P
24	UniProt	VAR_007050	Q	150	P	ANT3_HUMAN	Disease (AT3D)	765445413	A	Q	118	P
25	UniProt	VAR_007051	H	152	Y	ANT3_HUMAN	Disease (AT3D)	---	A	H	120	Y
26	UniProt	VAR_007053	L	158	P	ANT3_HUMAN	Disease (AT3D)	---	A	L	126	P
27	UniProt	VAR_027457	C	160	Y	ANT3_HUMAN	Disease (AT3D)	---	A	C	128	Y
28	UniProt	VAR_007054	R	161	Q	ANT3_HUMAN	Disease (AT3D)	121909563	A	R	129	Q
29	UniProt	VAR_012750	N	167	T	ANT3_HUMAN	Polymorphism	121909570	A	N	135	T
30	UniProt	VAR_071201	S	170	P	ANT3_HUMAN	Disease (AT3D)	---	A	S	138	P
31	UniProt	VAR_027458	L	178	H	ANT3_HUMAN	Disease (AT3D)	---	A	L	146	H
32	UniProt	VAR_027459	F	179	L	ANT3_HUMAN	Disease (AT3D)	---	A	F	147	L
33	UniProt	VAR_007055	Y	190	C	ANT3_HUMAN	Polymorphism	---	A	Y	158	C
34	UniProt	VAR_007056	Y	198	C	ANT3_HUMAN	Disease (AT3D)	---	A	Y	166	C
35	UniProt	VAR_027460	Y	198	H	ANT3_HUMAN	Disease (AT3D)	---	A	Y	166	H
36	UniProt	VAR_027461	S	214	F	ANT3_HUMAN	Disease (AT3D)	---	A	S	182	F
37	UniProt	VAR_007057	S	214	Y	ANT3_HUMAN	Disease (AT3D)	483352854	A	S	182	Y
38	UniProt	VAR_071202	I	218	N	ANT3_HUMAN	Disease (AT3D)	---	A	I	186	N
39	UniProt	VAR_007059	N	219	D	ANT3_HUMAN	Disease (AT3D)	121909571	A	N	187	D
40	UniProt	VAR_007058	N	219	K	ANT3_HUMAN	Disease (AT3D)	---	A	N	187	K
41	UniProt	VAR_027463	S	223	P	ANT3_HUMAN	Disease (AT3D)	121909572	A	S	191	P
42	UniProt	VAR_027464	T	243	I	ANT3_HUMAN	Disease (AT3D)	---	A	T	211	I
43	UniProt	VAR_071203	V	248	G	ANT3_HUMAN	Disease (AT3D)	---	A	V	216	G
44	UniProt	VAR_027465	I	251	T	ANT3_HUMAN	Disease (AT3D)	---	A	I	219	T
45	UniProt	VAR_027466	W	257	R	ANT3_HUMAN	Disease (AT3D)	---	A	W	225	R
46	UniProt	VAR_027467	F	261	L	ANT3_HUMAN	Disease (AT3D)	---	A	F	229	L
47	UniProt	VAR_007060	E	269	K	ANT3_HUMAN	Disease (AT3D)	758087836	A	E	237	K
48	UniProt	VAR_007062	M	283	I	ANT3_HUMAN	Disease (AT3D)	---	A	M	251	I
49	UniProt	VAR_027468	M	283	V	ANT3_HUMAN	Disease (AT3D)	---	A	M	251	V
50	UniProt	VAR_071204	R	293	P	ANT3_HUMAN	Disease (AT3D)	---	A	R	261	P
51	UniProt	VAR_007063	L	302	P	ANT3_HUMAN	Disease (AT3D)	---	A	L	270	P
52	UniProt	VAR_007064	I	316	N	ANT3_HUMAN	Disease (AT3D)	---	A	I	284	N
53	UniProt	VAR_027469	S	323	P	ANT3_HUMAN	Disease (AT3D)	---	A	S	291	P
54	UniProt	VAR_007065	E	334	K	ANT3_HUMAN	Disease (AT3D)	---	A	E	302	K
55	UniProt	VAR_007067	S	381	P	ANT3_HUMAN	Disease (AT3D)	121909565	A	S	349	P
56	UniProt	VAR_007068	R	391	Q	ANT3_HUMAN	Polymorphism	201541724	A	R	359	Q
57	UniProt	VAR_027470	S	397	P	ANT3_HUMAN	Disease (AT3D)	---	A	S	365	P
58	UniProt	VAR_027471	D	398	H	ANT3_HUMAN	Disease (AT3D)	---	A	D	366	H
59	UniProt	VAR_071205	H	401	R	ANT3_HUMAN	Disease (AT3D)	---	A	H	369	R
60	UniProt	VAR_027472	S	412	R	ANT3_HUMAN	Disease (AT3D)	---	A	S	380	R
61	UniProt	VAR_007069	A	414	T	ANT3_HUMAN	Disease (AT3D)	121909557	A	A	382	T
62	UniProt	VAR_007070	A	416	P	ANT3_HUMAN	Disease (AT3D)	28930978	A	A	384	P
63	UniProt	VAR_007071	A	416	S	ANT3_HUMAN	Disease (AT3D)	121909548	A	A	384	S
64	UniProt	VAR_007072	A	419	V	ANT3_HUMAN	Disease (AT3D)	121909568	A	A	387	V
65	UniProt	VAR_007073	G	424	D	ANT3_HUMAN	Disease (AT3D)	121909566	A	G	392	D
66	UniProt	VAR_007075	R	425	C	ANT3_HUMAN	Disease (AT3D)	121909554	A	R	393	C
67	UniProt	VAR_007074	R	425	H	ANT3_HUMAN	Disease (AT3D)	121909549	A	R	393	H
68	UniProt	VAR_007076	R	425	P	ANT3_HUMAN	Disease (AT3D)	121909549	A	R	393	P
69	UniProt	VAR_007077	S	426	L	ANT3_HUMAN	Disease (AT3D)	121909550	A	S	394	L
70	UniProt	VAR_007078	F	434	C	ANT3_HUMAN	Disease (AT3D)	---	A	F	402	C
71	UniProt	VAR_007080	F	434	L	ANT3_HUMAN	Disease (AT3D)	---	A	F	402	L
72	UniProt	VAR_007079	F	434	S	ANT3_HUMAN	Disease (AT3D)	---	A	F	402	S
73	UniProt	VAR_007081	A	436	T	ANT3_HUMAN	Disease (AT3D)	121909546	A	A	404	T
74	UniProt	VAR_007082	N	437	K	ANT3_HUMAN	Disease (AT3D)	---	A	N	405	K
75	UniProt	VAR_009258	R	438	G	ANT3_HUMAN	Disease (AT3D)	---	A	R	406	G
76	UniProt	VAR_007083	R	438	M	ANT3_HUMAN	Disease (AT3D)	---	A	R	406	M
77	UniProt	VAR_071206	P	439	A	ANT3_HUMAN	Disease (AT3D)	---	A	P	407	A
78	UniProt	VAR_007084	P	439	L	ANT3_HUMAN	Disease (AT3D)	121909555	A	P	407	L
79	UniProt	VAR_007085	P	439	T	ANT3_HUMAN	Disease (AT3D)	---	A	P	407	T
80	UniProt	VAR_027473	L	441	P	ANT3_HUMAN	Disease (AT3D)	---	A	L	409	P
81	UniProt	VAR_007086	I	453	T	ANT3_HUMAN	Disease (AT3D)	---	A	I	421	T
82	UniProt	VAR_007087	G	456	R	ANT3_HUMAN	Disease (AT3D)	---	A	G	424	R
83	UniProt	VAR_007088	R	457	T	ANT3_HUMAN	Disease (AT3D)	---	A	R	425	T
84	UniProt	VAR_007090	A	459	D	ANT3_HUMAN	Disease (AT3D)	---	A	A	427	D
85	UniProt	VAR_007091	P	461	L	ANT3_HUMAN	Disease (AT3D)	121909564	A	P	429	L
86	UniProt	VAR_007092	C	462	F	ANT3_HUMAN	Disease (AT3D)	---	A	C	430	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 2 (86, 86)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_007033	I	39	N	ANT3_HUMAN	Disease (AT3D)	28929468	B	I	7	N
02	UniProt	VAR_007034	M	52	T	ANT3_HUMAN	Unclassified	---	B	M	20	T
03	UniProt	VAR_071199	C	53	F	ANT3_HUMAN	Disease (AT3D)	---	B	C	21	F
04	UniProt	VAR_007035	R	56	C	ANT3_HUMAN	Disease (AT3D)	28929469	B	R	24	C
05	UniProt	VAR_007036	P	73	L	ANT3_HUMAN	Disease (AT3D)	121909551	B	P	41	L
06	UniProt	VAR_007037	R	79	C	ANT3_HUMAN	Disease (AT3D)	121909547	B	R	47	C
07	UniProt	VAR_007038	R	79	H	ANT3_HUMAN	Disease (AT3D)	121909552	B	R	47	H
08	UniProt	VAR_007039	R	79	S	ANT3_HUMAN	Disease (AT3D)	121909547	B	R	47	S
09	UniProt	VAR_007041	R	89	C	ANT3_HUMAN	Disease (AT3D)	147266200	B	R	57	C
10	UniProt	VAR_007042	F	90	L	ANT3_HUMAN	Disease (AT3D)	---	B	F	58	L
11	UniProt	VAR_027452	Y	95	C	ANT3_HUMAN	Disease (AT3D)	---	B	Y	63	C
12	UniProt	VAR_012316	Y	95	S	ANT3_HUMAN	Disease (AT3D)	---	B	Y	63	S
13	UniProt	VAR_027453	L	98	P	ANT3_HUMAN	Disease (AT3D)	---	B	L	66	P
14	UniProt	VAR_007044	P	112	T	ANT3_HUMAN	Disease (AT3D)	---	B	P	80	T
15	UniProt	VAR_027454	M	121	K	ANT3_HUMAN	Disease (AT3D)	---	B	M	89	K
16	UniProt	VAR_071200	G	125	D	ANT3_HUMAN	Disease (AT3D)	---	B	G	93	D
17	UniProt	VAR_027455	C	127	R	ANT3_HUMAN	Disease (AT3D)	121909573	B	C	95	R
18	UniProt	VAR_007045	L	131	F	ANT3_HUMAN	Disease (AT3D)	121909567	B	L	99	F
19	UniProt	VAR_007046	L	131	V	ANT3_HUMAN	Disease (AT3D)	---	B	L	99	V
20	UniProt	VAR_007047	Q	133	K	ANT3_HUMAN	Disease (AT3D)	---	B	Q	101	K
21	UniProt	VAR_027456	K	146	E	ANT3_HUMAN	Disease (AT3D)	---	B	K	114	E
22	UniProt	VAR_013085	T	147	A	ANT3_HUMAN	Polymorphism	2227606	B	T	115	A
23	UniProt	VAR_007049	S	148	P	ANT3_HUMAN	Disease (AT3D)	121909569	B	S	116	P
24	UniProt	VAR_007050	Q	150	P	ANT3_HUMAN	Disease (AT3D)	765445413	B	Q	118	P
25	UniProt	VAR_007051	H	152	Y	ANT3_HUMAN	Disease (AT3D)	---	B	H	120	Y
26	UniProt	VAR_007053	L	158	P	ANT3_HUMAN	Disease (AT3D)	---	B	L	126	P
27	UniProt	VAR_027457	C	160	Y	ANT3_HUMAN	Disease (AT3D)	---	B	C	128	Y
28	UniProt	VAR_007054	R	161	Q	ANT3_HUMAN	Disease (AT3D)	121909563	B	R	129	Q
29	UniProt	VAR_012750	N	167	T	ANT3_HUMAN	Polymorphism	121909570	B	N	135	T
30	UniProt	VAR_071201	S	170	P	ANT3_HUMAN	Disease (AT3D)	---	B	S	138	P
31	UniProt	VAR_027458	L	178	H	ANT3_HUMAN	Disease (AT3D)	---	B	L	146	H
32	UniProt	VAR_027459	F	179	L	ANT3_HUMAN	Disease (AT3D)	---	B	F	147	L
33	UniProt	VAR_007055	Y	190	C	ANT3_HUMAN	Polymorphism	---	B	Y	158	C
34	UniProt	VAR_007056	Y	198	C	ANT3_HUMAN	Disease (AT3D)	---	B	Y	166	C
35	UniProt	VAR_027460	Y	198	H	ANT3_HUMAN	Disease (AT3D)	---	B	Y	166	H
36	UniProt	VAR_027461	S	214	F	ANT3_HUMAN	Disease (AT3D)	---	B	S	182	F
37	UniProt	VAR_007057	S	214	Y	ANT3_HUMAN	Disease (AT3D)	483352854	B	S	182	Y
38	UniProt	VAR_071202	I	218	N	ANT3_HUMAN	Disease (AT3D)	---	B	I	186	N
39	UniProt	VAR_007059	N	219	D	ANT3_HUMAN	Disease (AT3D)	121909571	B	N	187	D
40	UniProt	VAR_007058	N	219	K	ANT3_HUMAN	Disease (AT3D)	---	B	N	187	K
41	UniProt	VAR_027463	S	223	P	ANT3_HUMAN	Disease (AT3D)	121909572	B	S	191	P
42	UniProt	VAR_027464	T	243	I	ANT3_HUMAN	Disease (AT3D)	---	B	T	211	I
43	UniProt	VAR_071203	V	248	G	ANT3_HUMAN	Disease (AT3D)	---	B	V	216	G
44	UniProt	VAR_027465	I	251	T	ANT3_HUMAN	Disease (AT3D)	---	B	I	219	T
45	UniProt	VAR_027466	W	257	R	ANT3_HUMAN	Disease (AT3D)	---	B	W	225	R
46	UniProt	VAR_027467	F	261	L	ANT3_HUMAN	Disease (AT3D)	---	B	F	229	L
47	UniProt	VAR_007060	E	269	K	ANT3_HUMAN	Disease (AT3D)	758087836	B	E	237	K
48	UniProt	VAR_007062	M	283	I	ANT3_HUMAN	Disease (AT3D)	---	B	M	251	I
49	UniProt	VAR_027468	M	283	V	ANT3_HUMAN	Disease (AT3D)	---	B	M	251	V
50	UniProt	VAR_071204	R	293	P	ANT3_HUMAN	Disease (AT3D)	---	B	R	261	P
51	UniProt	VAR_007063	L	302	P	ANT3_HUMAN	Disease (AT3D)	---	B	L	270	P
52	UniProt	VAR_007064	I	316	N	ANT3_HUMAN	Disease (AT3D)	---	B	I	284	N
53	UniProt	VAR_027469	S	323	P	ANT3_HUMAN	Disease (AT3D)	---	B	S	291	P
54	UniProt	VAR_007065	E	334	K	ANT3_HUMAN	Disease (AT3D)	---	B	E	302	K
55	UniProt	VAR_007067	S	381	P	ANT3_HUMAN	Disease (AT3D)	121909565	B	S	349	P
56	UniProt	VAR_007068	R	391	Q	ANT3_HUMAN	Polymorphism	201541724	B	R	359	Q
57	UniProt	VAR_027470	S	397	P	ANT3_HUMAN	Disease (AT3D)	---	B	S	365	P
58	UniProt	VAR_027471	D	398	H	ANT3_HUMAN	Disease (AT3D)	---	B	D	366	H
59	UniProt	VAR_071205	H	401	R	ANT3_HUMAN	Disease (AT3D)	---	B	H	369	R
60	UniProt	VAR_027472	S	412	R	ANT3_HUMAN	Disease (AT3D)	---	B	S	380	R
61	UniProt	VAR_007069	A	414	T	ANT3_HUMAN	Disease (AT3D)	121909557	B	A	382	T
62	UniProt	VAR_007070	A	416	P	ANT3_HUMAN	Disease (AT3D)	28930978	B	A	384	P
63	UniProt	VAR_007071	A	416	S	ANT3_HUMAN	Disease (AT3D)	121909548	B	A	384	S
64	UniProt	VAR_007072	A	419	V	ANT3_HUMAN	Disease (AT3D)	121909568	B	A	387	V
65	UniProt	VAR_007073	G	424	D	ANT3_HUMAN	Disease (AT3D)	121909566	B	G	392	D
66	UniProt	VAR_007075	R	425	C	ANT3_HUMAN	Disease (AT3D)	121909554	B	R	393	C
67	UniProt	VAR_007074	R	425	H	ANT3_HUMAN	Disease (AT3D)	121909549	B	R	393	H
68	UniProt	VAR_007076	R	425	P	ANT3_HUMAN	Disease (AT3D)	121909549	B	R	393	P
69	UniProt	VAR_007077	S	426	L	ANT3_HUMAN	Disease (AT3D)	121909550	B	S	394	L
70	UniProt	VAR_007078	F	434	C	ANT3_HUMAN	Disease (AT3D)	---	B	F	402	C
71	UniProt	VAR_007080	F	434	L	ANT3_HUMAN	Disease (AT3D)	---	B	F	402	L
72	UniProt	VAR_007079	F	434	S	ANT3_HUMAN	Disease (AT3D)	---	B	F	402	S
73	UniProt	VAR_007081	A	436	T	ANT3_HUMAN	Disease (AT3D)	121909546	B	A	404	T
74	UniProt	VAR_007082	N	437	K	ANT3_HUMAN	Disease (AT3D)	---	B	N	405	K
75	UniProt	VAR_009258	R	438	G	ANT3_HUMAN	Disease (AT3D)	---	B	R	406	G
76	UniProt	VAR_007083	R	438	M	ANT3_HUMAN	Disease (AT3D)	---	B	R	406	M
77	UniProt	VAR_071206	P	439	A	ANT3_HUMAN	Disease (AT3D)	---	B	P	407	A
78	UniProt	VAR_007084	P	439	L	ANT3_HUMAN	Disease (AT3D)	121909555	B	P	407	L
79	UniProt	VAR_007085	P	439	T	ANT3_HUMAN	Disease (AT3D)	---	B	P	407	T
80	UniProt	VAR_027473	L	441	P	ANT3_HUMAN	Disease (AT3D)	---	B	L	409	P
81	UniProt	VAR_007086	I	453	T	ANT3_HUMAN	Disease (AT3D)	---	B	I	421	T
82	UniProt	VAR_007087	G	456	R	ANT3_HUMAN	Disease (AT3D)	---	B	G	424	R
83	UniProt	VAR_007088	R	457	T	ANT3_HUMAN	Disease (AT3D)	---	B	R	425	T
84	UniProt	VAR_007090	A	459	D	ANT3_HUMAN	Disease (AT3D)	---	B	A	427	D
85	UniProt	VAR_007091	P	461	L	ANT3_HUMAN	Disease (AT3D)	121909564	B	P	429	L
86	UniProt	VAR_007092	C	462	F	ANT3_HUMAN	Disease (AT3D)	---	B	C	430	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Biological Unit 3 (86, 86)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
01	UniProt	VAR_007033	I	39	N	ANT3_HUMAN	Disease (AT3D)	28929468	C	I	7	N
02	UniProt	VAR_007034	M	52	T	ANT3_HUMAN	Unclassified	---	C	M	20	T
03	UniProt	VAR_071199	C	53	F	ANT3_HUMAN	Disease (AT3D)	---	C	C	21	F
04	UniProt	VAR_007035	R	56	C	ANT3_HUMAN	Disease (AT3D)	28929469	C	R	24	C
05	UniProt	VAR_007036	P	73	L	ANT3_HUMAN	Disease (AT3D)	121909551	C	P	41	L
06	UniProt	VAR_007037	R	79	C	ANT3_HUMAN	Disease (AT3D)	121909547	C	R	47	C
07	UniProt	VAR_007038	R	79	H	ANT3_HUMAN	Disease (AT3D)	121909552	C	R	47	H
08	UniProt	VAR_007039	R	79	S	ANT3_HUMAN	Disease (AT3D)	121909547	C	R	47	S
09	UniProt	VAR_007041	R	89	C	ANT3_HUMAN	Disease (AT3D)	147266200	C	R	57	C
10	UniProt	VAR_007042	F	90	L	ANT3_HUMAN	Disease (AT3D)	---	C	F	58	L
11	UniProt	VAR_027452	Y	95	C	ANT3_HUMAN	Disease (AT3D)	---	C	Y	63	C
12	UniProt	VAR_012316	Y	95	S	ANT3_HUMAN	Disease (AT3D)	---	C	Y	63	S
13	UniProt	VAR_027453	L	98	P	ANT3_HUMAN	Disease (AT3D)	---	C	L	66	P
14	UniProt	VAR_007044	P	112	T	ANT3_HUMAN	Disease (AT3D)	---	C	P	80	T
15	UniProt	VAR_027454	M	121	K	ANT3_HUMAN	Disease (AT3D)	---	C	M	89	K
16	UniProt	VAR_071200	G	125	D	ANT3_HUMAN	Disease (AT3D)	---	C	G	93	D
17	UniProt	VAR_027455	C	127	R	ANT3_HUMAN	Disease (AT3D)	121909573	C	C	95	R
18	UniProt	VAR_007045	L	131	F	ANT3_HUMAN	Disease (AT3D)	121909567	C	L	99	F
19	UniProt	VAR_007046	L	131	V	ANT3_HUMAN	Disease (AT3D)	---	C	L	99	V
20	UniProt	VAR_007047	Q	133	K	ANT3_HUMAN	Disease (AT3D)	---	C	Q	101	K
21	UniProt	VAR_027456	K	146	E	ANT3_HUMAN	Disease (AT3D)	---	C	K	114	E
22	UniProt	VAR_013085	T	147	A	ANT3_HUMAN	Polymorphism	2227606	C	T	115	A
23	UniProt	VAR_007049	S	148	P	ANT3_HUMAN	Disease (AT3D)	121909569	C	S	116	P
24	UniProt	VAR_007050	Q	150	P	ANT3_HUMAN	Disease (AT3D)	765445413	C	Q	118	P
25	UniProt	VAR_007051	H	152	Y	ANT3_HUMAN	Disease (AT3D)	---	C	H	120	Y
26	UniProt	VAR_007053	L	158	P	ANT3_HUMAN	Disease (AT3D)	---	C	L	126	P
27	UniProt	VAR_027457	C	160	Y	ANT3_HUMAN	Disease (AT3D)	---	C	C	128	Y
28	UniProt	VAR_007054	R	161	Q	ANT3_HUMAN	Disease (AT3D)	121909563	C	R	129	Q
29	UniProt	VAR_012750	N	167	T	ANT3_HUMAN	Polymorphism	121909570	C	N	135	T
30	UniProt	VAR_071201	S	170	P	ANT3_HUMAN	Disease (AT3D)	---	C	S	138	P
31	UniProt	VAR_027458	L	178	H	ANT3_HUMAN	Disease (AT3D)	---	C	L	146	H
32	UniProt	VAR_027459	F	179	L	ANT3_HUMAN	Disease (AT3D)	---	C	F	147	L
33	UniProt	VAR_007055	Y	190	C	ANT3_HUMAN	Polymorphism	---	C	Y	158	C
34	UniProt	VAR_007056	Y	198	C	ANT3_HUMAN	Disease (AT3D)	---	C	Y	166	C
35	UniProt	VAR_027460	Y	198	H	ANT3_HUMAN	Disease (AT3D)	---	C	Y	166	H
36	UniProt	VAR_027461	S	214	F	ANT3_HUMAN	Disease (AT3D)	---	C	S	182	F
37	UniProt	VAR_007057	S	214	Y	ANT3_HUMAN	Disease (AT3D)	483352854	C	S	182	Y
38	UniProt	VAR_071202	I	218	N	ANT3_HUMAN	Disease (AT3D)	---	C	I	186	N
39	UniProt	VAR_007059	N	219	D	ANT3_HUMAN	Disease (AT3D)	121909571	C	N	187	D
40	UniProt	VAR_007058	N	219	K	ANT3_HUMAN	Disease (AT3D)	---	C	N	187	K
41	UniProt	VAR_027463	S	223	P	ANT3_HUMAN	Disease (AT3D)	121909572	C	S	191	P
42	UniProt	VAR_027464	T	243	I	ANT3_HUMAN	Disease (AT3D)	---	C	T	211	I
43	UniProt	VAR_071203	V	248	G	ANT3_HUMAN	Disease (AT3D)	---	C	V	216	G
44	UniProt	VAR_027465	I	251	T	ANT3_HUMAN	Disease (AT3D)	---	C	I	219	T
45	UniProt	VAR_027466	W	257	R	ANT3_HUMAN	Disease (AT3D)	---	C	W	225	R
46	UniProt	VAR_027467	F	261	L	ANT3_HUMAN	Disease (AT3D)	---	C	F	229	L
47	UniProt	VAR_007060	E	269	K	ANT3_HUMAN	Disease (AT3D)	758087836	C	E	237	K
48	UniProt	VAR_007062	M	283	I	ANT3_HUMAN	Disease (AT3D)	---	C	M	251	I
49	UniProt	VAR_027468	M	283	V	ANT3_HUMAN	Disease (AT3D)	---	C	M	251	V
50	UniProt	VAR_071204	R	293	P	ANT3_HUMAN	Disease (AT3D)	---	C	R	261	P
51	UniProt	VAR_007063	L	302	P	ANT3_HUMAN	Disease (AT3D)	---	C	L	270	P
52	UniProt	VAR_007064	I	316	N	ANT3_HUMAN	Disease (AT3D)	---	C	I	284	N
53	UniProt	VAR_027469	S	323	P	ANT3_HUMAN	Disease (AT3D)	---	C	S	291	P
54	UniProt	VAR_007065	E	334	K	ANT3_HUMAN	Disease (AT3D)	---	C	E	302	K
55	UniProt	VAR_007067	S	381	P	ANT3_HUMAN	Disease (AT3D)	121909565	C	S	349	P
56	UniProt	VAR_007068	R	391	Q	ANT3_HUMAN	Polymorphism	201541724	C	R	359	Q
57	UniProt	VAR_027470	S	397	P	ANT3_HUMAN	Disease (AT3D)	---	C	S	365	P
58	UniProt	VAR_027471	D	398	H	ANT3_HUMAN	Disease (AT3D)	---	C	D	366	H
59	UniProt	VAR_071205	H	401	R	ANT3_HUMAN	Disease (AT3D)	---	C	H	369	R
60	UniProt	VAR_027472	S	412	R	ANT3_HUMAN	Disease (AT3D)	---	C	S	380	R
61	UniProt	VAR_007069	A	414	T	ANT3_HUMAN	Disease (AT3D)	121909557	C	A	382	T
62	UniProt	VAR_007070	A	416	P	ANT3_HUMAN	Disease (AT3D)	28930978	C	A	384	P
63	UniProt	VAR_007071	A	416	S	ANT3_HUMAN	Disease (AT3D)	121909548	C	A	384	S
64	UniProt	VAR_007072	A	419	V	ANT3_HUMAN	Disease (AT3D)	121909568	C	A	387	V
65	UniProt	VAR_007073	G	424	D	ANT3_HUMAN	Disease (AT3D)	121909566	C	G	392	D
66	UniProt	VAR_007075	R	425	C	ANT3_HUMAN	Disease (AT3D)	121909554	C	R	393	C
67	UniProt	VAR_007074	R	425	H	ANT3_HUMAN	Disease (AT3D)	121909549	C	R	393	H
68	UniProt	VAR_007076	R	425	P	ANT3_HUMAN	Disease (AT3D)	121909549	C	R	393	P
69	UniProt	VAR_007077	S	426	L	ANT3_HUMAN	Disease (AT3D)	121909550	C	S	394	L
70	UniProt	VAR_007078	F	434	C	ANT3_HUMAN	Disease (AT3D)	---	C	F	402	C
71	UniProt	VAR_007080	F	434	L	ANT3_HUMAN	Disease (AT3D)	---	C	F	402	L
72	UniProt	VAR_007079	F	434	S	ANT3_HUMAN	Disease (AT3D)	---	C	F	402	S
73	UniProt	VAR_007081	A	436	T	ANT3_HUMAN	Disease (AT3D)	121909546	C	A	404	T
74	UniProt	VAR_007082	N	437	K	ANT3_HUMAN	Disease (AT3D)	---	C	N	405	K
75	UniProt	VAR_009258	R	438	G	ANT3_HUMAN	Disease (AT3D)	---	C	R	406	G
76	UniProt	VAR_007083	R	438	M	ANT3_HUMAN	Disease (AT3D)	---	C	R	406	M
77	UniProt	VAR_071206	P	439	A	ANT3_HUMAN	Disease (AT3D)	---	C	P	407	A
78	UniProt	VAR_007084	P	439	L	ANT3_HUMAN	Disease (AT3D)	121909555	C	P	407	L
79	UniProt	VAR_007085	P	439	T	ANT3_HUMAN	Disease (AT3D)	---	C	P	407	T
80	UniProt	VAR_027473	L	441	P	ANT3_HUMAN	Disease (AT3D)	---	C	L	409	P
81	UniProt	VAR_007086	I	453	T	ANT3_HUMAN	Disease (AT3D)	---	C	I	421	T
82	UniProt	VAR_007087	G	456	R	ANT3_HUMAN	Disease (AT3D)	---	C	G	424	R
83	UniProt	VAR_007088	R	457	T	ANT3_HUMAN	Disease (AT3D)	---	C	R	425	T
84	UniProt	VAR_007090	A	459	D	ANT3_HUMAN	Disease (AT3D)	---	C	A	427	D
85	UniProt	VAR_007091	P	461	L	ANT3_HUMAN	Disease (AT3D)	121909564	C	P	429	L
86	UniProt	VAR_007092	C	462	F	ANT3_HUMAN	Disease (AT3D)	---	C	C	430	F

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

Asymmetric Unit (1, 3)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	SERPIN	PS00284	Serpins signature.	ANT3_HUMAN	434-444	3	A:402-412 B:402-412 C:402-412

Biological Unit 1 (1, 1)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	SERPIN	PS00284	Serpins signature.	ANT3_HUMAN	434-444	1	A:402-412 - -

Biological Unit 2 (1, 1)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	SERPIN	PS00284	Serpins signature.	ANT3_HUMAN	434-444	1	- B:402-412 -

Biological Unit 3 (1, 1)

	PROSITE			UniProtKB		PDB
No.	ID	AC	Description	ID	Location	Count	Location
1	SERPIN	PS00284	Serpins signature.	ANT3_HUMAN	434-444	1	- - C:402-412

Asymmetric Unit (6, 18)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.1a	ENST00000367698	1a	ENSE00001944151	chr1:173886516-173886357	160	ANT3_HUMAN	1-14	14	0	-	-
1.3a	ENST00000367698	3a	ENSE00000814673	chr1:173884057-173883691	367	ANT3_HUMAN	14-136	123	3	A:2-104 (gaps) B:2-104 (gaps) C:2-104 (gaps)	103 103 103
1.4c	ENST00000367698	4c	ENSE00000789910	chr1:173881152-173880937	216	ANT3_HUMAN	137-208	72	3	A:105-176 B:105-176 C:105-176	72 72 72
1.5a	ENST00000367698	5a	ENSE00000789909	chr1:173880029-173879892	138	ANT3_HUMAN	209-254	46	3	A:177-222 B:177-222 C:177-222	46 46 46
1.6b	ENST00000367698	6b	ENSE00000789908	chr1:173879080-173878690	391	ANT3_HUMAN	255-385	131	3	A:223-353 B:223-353 C:223-353	131 131 131
1.7a	ENST00000367698	7a	ENSE00001383315	chr1:173876652-173876588	65	ANT3_HUMAN	385-406	22	3	A:353-374 B:353-374 C:353-374	22 22 22
1.8a	ENST00000367698	8a	ENSE00001876994	chr1:173873203-173872947	257	ANT3_HUMAN	407-464	58	3	A:375-432 B:375-432 C:375-432	58 58 58

Asymmetric Unit

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:419
 aligned with ANT3_HUMAN | P01008 from UniProtKB/Swiss-Prot  Length:464

    Alignment length:431
                                    43        53        63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323       333       343       353       363       373       383       393       403       413       423       433       443       453       463 
           ANT3_HUMAN    34 GSPVDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCVK 464
               SCOP domains d1t1fa_ A: Antithrombin                                                                                                                                                                                                                                                                                                                                                                                                                         SCOP domains
               CATH domains ----------1t1fA01 A:12-            224,A:321-377 Antithrombin, subunit I, domain 2                                                                                                                                             1t1fA02 A:225-320,A:380-429 Alpha-1-antitrypsin, domain 1                                       1t1fA01 A:12-224,A:321-377                               --1t1fA02 A:225-320,A:380-429                       --- CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .......................------------........hhhhhhhhhhhhhhhhhhhhhhhhhh.....eeehhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh.....eeeeeeeeeeee.....hhhhhhhhhhhh...eeee....hhhhhhhhhhhhhhhhh..................eeeeeeeeeeee.....hhhhheeeeee.....eeeeeeeeeeeeeeeee.hhh.eeeeee.....eeeeeee.....hhhhhhhhhhhhhhhhhhhhheeeeeeeeee.eeeeeee.hhhhhhhh..hhhhh..................eeeeeeeeeeee...ee.....................ee....eeeeeee....eeeeeeee...... Sec.struct. author
             SAPs(SNPs) (1) -----N------------TF--C----------------L-----C---------CL----C--P-------------T--------K---D-R---F-K------------EAP-P-Y-----P-YQ-----T--P-------HL----------C-------C---------------F---ND---P-------------------I----G--T-----R---L-------K-------------I---------P--------P-------------N------P----------K----------------------------------------------P---------Q-----PH--R----------R-T-P--V----DCL-------C-TKGA-P-----------T--RT-D-LF-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---------------------------------------------H---------------S-----------------------------------V------------------------------------------------------------------H---------------Y----K---------------------------------------------------------------V------------------------------------------------------------------------------------------------------------------------------------S--------H--------L---ML------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ---------------------------------------------S---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--------S----T------------------------- SAPs(SNPs) (3)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SERPIN     -------------------- PROSITE
           Transcript 1 (1) Exon 1.3a  PDB: A:2-104 (gaps) UniProt: 14-136 [INCOMPLETE]                                            Exon 1.4c  PDB: A:105-176 UniProt: 137-208                              Exon 1.5a  PDB: A:177-222 UniProt: 209-254    Exon 1.6b  PDB: A:223-353 UniProt: 255-385                                                                                         ---------------------Exon 1.8a  PDB: A:375-432 UniProt: 407-464                 Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.7a             ---------------------------------------------------------- Transcript 1 (2)
                 1t1f A   2 GSPVDICTAKPRDIPMNPMCIYR------------EQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLCVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVCFKANRPFLVFIREVPLNTIIFMGRVANPCVK 432
                                    11        21  |      -     |  41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421       431 
                                                 24           37

Chain B from PDB  Type:PROTEIN  Length:419
 aligned with ANT3_HUMAN | P01008 from UniProtKB/Swiss-Prot  Length:464

    Alignment length:431
                                    43        53        63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323       333       343       353       363       373       383       393       403       413       423       433       443       453       463 
           ANT3_HUMAN    34 GSPVDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCVK 464
               SCOP domains d1t1fb_ B: Antithrombin                                                                                                                                                                                                                                                                                                                                                                                                                         SCOP domains
               CATH domains ----------1t1fB01 B:12-            224,B:321-377 Antithrombin, subunit I, domain 2                                                                                                                                             1t1fB02 B:225-320,B:380-429 Alpha-1-antitrypsin, domain 1                                       1t1fB01 B:12-224,B:321-377                               --1t1fB02 B:225-320,B:380-429                       --- CATH domains
               Pfam domains ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- Pfam domains
         Sec.struct. author .......................------------........hhhhhhhhhhhhhhhhhhhhhhhhhh.....eeehhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh.....eeeeeeeeeeee.....hhhhhhhhhhhh...eeee....hhhhhhhhhhhhhhhhh..................eeeeeeeeeeee.....hhhhheeeeee.....eeeeeeeeeeeeeeeee.hhh.eeeeee.....eeeeeee.....hhhhhhhhhhhhhhhhhhhhheeeeeeeeee.eeeeeee.hhhhhhhh..hhhhh..................eeeeeeeeeeee...ee.....................ee....eeeeeee....eeeeeeee...... Sec.struct. author
             SAPs(SNPs) (1) -----N------------TF--C----------------L-----C---------CL----C--P-------------T--------K---D-R---F-K------------EAP-P-Y-----P-YQ-----T--P-------HL----------C-------C---------------F---ND---P-------------------I----G--T-----R---L-------K-------------I---------P--------P-------------N------P----------K----------------------------------------------P---------Q-----PH--R----------R-T-P--V----DCL-------C-TKGA-P-----------T--RT-D-LF-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---------------------------------------------H---------------S-----------------------------------V------------------------------------------------------------------H---------------Y----K---------------------------------------------------------------V------------------------------------------------------------------------------------------------------------------------------------S--------H--------L---ML------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ---------------------------------------------S---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--------S----T------------------------- SAPs(SNPs) (3)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SERPIN     -------------------- PROSITE
           Transcript 1 (1) Exon 1.3a  PDB: B:2-104 (gaps) UniProt: 14-136 [INCOMPLETE]                                            Exon 1.4c  PDB: B:105-176 UniProt: 137-208                              Exon 1.5a  PDB: B:177-222 UniProt: 209-254    Exon 1.6b  PDB: B:223-353 UniProt: 255-385                                                                                         ---------------------Exon 1.8a  PDB: B:375-432 UniProt: 407-464                 Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.7a             ---------------------------------------------------------- Transcript 1 (2)
                 1t1f B   2 GSPVDICTAKPRDIPMNPMCIYR------------EQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLCVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVCFKANRPFLVFIREVPLNTIIFMGRVANPCVK 432
                                    11        21  |      -     |  41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421       431 
                                                 24           37

Chain C from PDB  Type:PROTEIN  Length:419
 aligned with ANT3_HUMAN | P01008 from UniProtKB/Swiss-Prot  Length:464

    Alignment length:431
                                    43        53        63        73        83        93       103       113       123       133       143       153       163       173       183       193       203       213       223       233       243       253       263       273       283       293       303       313       323       333       343       353       363       373       383       393       403       413       423       433       443       453       463 
           ANT3_HUMAN    34 GSPVDICTAKPRDIPMNPMCIYRSPEKKATEDEGSEQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKSSKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCVK 464
               SCOP domains d1t1fc_ C: Antithrombin                                                                                                                                                                                                                                                                                                                                                                                                                         SCOP domains
               CATH domains ----------1t1fC01 C:12-            224,C:321-377 Antithrombin, subunit I, domain 2                                                                                                                                             1t1fC02 C:225-320,C:380-429 Alpha-1-antitrypsin, domain 1                                       1t1fC01 C:12-224,C:321-377                               --1t1fC02 C:225-320,C:380-429                       --- CATH domains
           Pfam domains (1) ---------------------------------------------------Serpin-1t1fC01 C:53-429                                                                                                                                                                                                                                                                                                                                                                  --- Pfam domains (1)
           Pfam domains (2) ---------------------------------------------------Serpin-1t1fC02 C:53-429                                                                                                                                                                                                                                                                                                                                                                  --- Pfam domains (2)
           Pfam domains (3) ---------------------------------------------------Serpin-1t1fC03 C:53-429                                                                                                                                                                                                                                                                                                                                                                  --- Pfam domains (3)
         Sec.struct. author .......................------------........hhhhhhhhhhhhhhhhhhhhhhhhhh.....eeehhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhhh.....eeeeeeeeeeee.....hhhhhhhhhhhh...eeee....hhhhhhhhhhhhhhhhh..................eeeeeeeeeeee.....hhhhheeeeee.....eeeeeeeeeeeeeeeee.hhh.eeeeee.....eeeeeee.....hhhhhhhhhhhhhhhhhhhhheeeeeeeeee.eeeeeee.hhhhhhhh..hhhhh..................eeeeeeeeeeee...ee.....................ee....eeeeeee....eeeeeeee...... Sec.struct. author
             SAPs(SNPs) (1) -----N------------TF--C----------------L-----C---------CL----C--P-------------T--------K---D-R---F-K------------EAP-P-Y-----P-YQ-----T--P-------HL----------C-------C---------------F---ND---P-------------------I----G--T-----R---L-------K-------------I---------P--------P-------------N------P----------K----------------------------------------------P---------Q-----PH--R----------R-T-P--V----DCL-------C-TKGA-P-----------T--RT-D-LF-- SAPs(SNPs) (1)
             SAPs(SNPs) (2) ---------------------------------------------H---------------S-----------------------------------V------------------------------------------------------------------H---------------Y----K---------------------------------------------------------------V------------------------------------------------------------------------------------------------------------------------------------S--------H--------L---ML------------------------- SAPs(SNPs) (2)
             SAPs(SNPs) (3) ---------------------------------------------S---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------P--------S----T------------------------- SAPs(SNPs) (3)
                    PROSITE ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------SERPIN     -------------------- PROSITE
           Transcript 1 (1) Exon 1.3a  PDB: C:2-104 (gaps) UniProt: 14-136 [INCOMPLETE]                                            Exon 1.4c  PDB: C:105-176 UniProt: 137-208                              Exon 1.5a  PDB: C:177-222 UniProt: 209-254    Exon 1.6b  PDB: C:223-353 UniProt: 255-385                                                                                         ---------------------Exon 1.8a  PDB: C:375-432 UniProt: 407-464                 Transcript 1 (1)
           Transcript 1 (2) ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------Exon 1.7a             ---------------------------------------------------------- Transcript 1 (2)
                 1t1f C   2 GSPVDICTAKPRDIPMNPMCIYR------------EQKIPEATNRRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCRLYRKANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDDITMVLILPKPEKSLAKVEKELTPEVLQEWLDELEEMMLCVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEGRDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLNPNRVCFKANRPFLVFIREVPLNTIIFMGRVANPCVK 432
                                    11        21  |      -     |  41        51        61        71        81        91       101       111       121       131       141       151       161       171       181       191       201       211       221       231       241       251       261       271       281       291       301       311       321       331       341       351       361       371       381       391       401       411       421       431 
                                                 24           37

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

Asymmetric Unit

Classes(

)

Folds(

)

Superfamilies( (-)

)

Families(

)

Protein Domains( (-)

)

Organisms( (-)

)

Class: Multi-domain proteins (alpha and beta) (2421)

Fold: Serpins (120)

Superfamily: Serpins (120)

Family: Serpins (100)

Protein domain: Antithrombin (28)

Human (Homo sapiens) [TaxId: 9606] (27)

1a	d1t1fa_	A:
1b	d1t1fb_	B:
1c	d1t1fc_	C:

Asymmetric Unit

Classes(

)

Architectures( (-)

)

Topologies( (-)

)

Homologous Superfamilies( (-)

)

Organisms( (-)

)

Class: Alpha Beta (26913)

Architecture: 2-Layer Sandwich (8480)

Topology: Antithrombin; Chain I, domain 2 (100)

Homologous Superfamily: Antithrombin, subunit I, domain 2 (100)

Human (Homo sapiens) (80)

1a	1t1fA01	A:12-224,A:321-377
1b	1t1fB01	B:12-224,B:321-377
1c	1t1fC01	C:12-224,C:321-377

Class: Mainly Beta (13760)

Architecture: Roll (1513)

Topology: Alpha-1-antitrypsin; domain 1 (101)

Homologous Superfamily: Alpha-1-antitrypsin, domain 1 (101)

Human (Homo sapiens) (81)

2a	1t1fA02	A:225-320,A:380-429
2b	1t1fB02	B:225-320,B:380-429
2c	1t1fC02	C:225-320,C:380-429

Asymmetric Unit

Clans(

)

Families(

)

Organisms( (-)

)

Clan: no clan defined [family: Serpin] (63)

Family: Serpin (63)

Homo sapiens (Human) (41)

1a	Serpin-1t1fC01	C:53-429
1b	Serpin-1t1fC02	C:53-429
1c	Serpin-1t1fC03	C:53-429

Asymmetric Unit(hide GO term definitions)

Chain A,B,C (ANT3_HUMAN | P01008)

molecular function
	GO:0008201	heparin binding	Interacting selectively and non-covalently with heparin, any member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.
	GO:0030414	peptidase inhibitor activity	Stops, prevents or reduces the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds.
	GO:0002020	protease binding	Interacting selectively and non-covalently with any protease or peptidase.
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004867	serine-type endopeptidase inhibitor activity	Stops, prevents or reduces the activity of serine-type endopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain; a serine residue (and a histidine residue) are at the active center of the enzyme.
biological process
	GO:0007596	blood coagulation	The sequential process in which the multiple coagulation factors of the blood interact, ultimately resulting in the formation of an insoluble fibrin clot; it may be divided into three stages: stage 1, the formation of intrinsic and extrinsic prothrombin converting principle; stage 2, the formation of thrombin; stage 3, the formation of stable fibrin polymers.
	GO:0007599	hemostasis	The stopping of bleeding (loss of body fluid) or the arrest of the circulation to an organ or part.
	GO:0010951	negative regulation of endopeptidase activity	Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins.
	GO:0050728	negative regulation of inflammatory response	Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.
	GO:0010466	negative regulation of peptidase activity	Any process that stops or reduces the rate of peptidase activity, the hydrolysis of peptide bonds within proteins.
	GO:2000266	regulation of blood coagulation, intrinsic pathway	Any process that modulates the frequency, rate or extent of blood coagulation, intrinsic pathway.
	GO:0007584	response to nutrient	Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a nutrient stimulus.
cellular component
	GO:0072562	blood microparticle	A phospholipid microvesicle that is derived from any of several cell types, such as platelets, blood cells, endothelial cells, or others, and contains membrane receptors as well as other proteins characteristic of the parental cell. Microparticles are heterogeneous in size, and are characterized as microvesicles free of nucleic acids.
	GO:0070062	extracellular exosome	A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm.
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005615	extracellular space	That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

Asymmetric Unit
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
		BMA	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		GOL	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		IOD	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]
		NAG	[ RasMol \| Jena3D ]	+environment [ RasMol \| Jena3D ]

	Sites
		AC1	[ RasMol ]	+environment [ RasMol ]
		AC2	[ RasMol ]	+environment [ RasMol ]
		AC3	[ RasMol ]	+environment [ RasMol ]
		AC4	[ RasMol ]	+environment [ RasMol ]
		AC5	[ RasMol ]	+environment [ RasMol ]
		AC6	[ RasMol ]	+environment [ RasMol ]
		AC7	[ RasMol ]	+environment [ RasMol ]
		AC8	[ RasMol ]	+environment [ RasMol ]
		AC9	[ RasMol ]	+environment [ RasMol ]
		BC1	[ RasMol ]	+environment [ RasMol ]
		BC2	[ RasMol ]	+environment [ RasMol ]
		BC3	[ RasMol ]	+environment [ RasMol ]
		BC4	[ RasMol ]	+environment [ RasMol ]
		BC5	[ RasMol ]	+environment [ RasMol ]
		BC6	[ RasMol ]	+environment [ RasMol ]
		BC7	[ RasMol ]	+environment [ RasMol ]
		BC8	[ RasMol ]	+environment [ RasMol ]
		BC9	[ RasMol ]	+environment [ RasMol ]
		CC1	[ RasMol ]	+environment [ RasMol ]
		CC2	[ RasMol ]	+environment [ RasMol ]
		CC3	[ RasMol ]	+environment [ RasMol ]
		CC4	[ RasMol ]	+environment [ RasMol ]
		CC5	[ RasMol ]	+environment [ RasMol ]
		CC6	[ RasMol ]	+environment [ RasMol ]
		CC7	[ RasMol ]	+environment [ RasMol ]
		CC8	[ RasMol ]	+environment [ RasMol ]
		CC9	[ RasMol ]	+environment [ RasMol ]
		DC1	[ RasMol ]	+environment [ RasMol ]
		DC2	[ RasMol ]	+environment [ RasMol ]
		DC3	[ RasMol ]	+environment [ RasMol ]
		DC4	[ RasMol ]	+environment [ RasMol ]
		DC5	[ RasMol ]	+environment [ RasMol ]
		DC6	[ RasMol ]	+environment [ RasMol ]
		DC7	[ RasMol ]	+environment [ RasMol ]
		DC8	[ RasMol ]	+environment [ RasMol ]
		DC9	[ RasMol ]	+environment [ RasMol ]
		EC1	[ RasMol ]	+environment [ RasMol ]
		EC2	[ RasMol ]	+environment [ RasMol ]
		EC3	[ RasMol ]	+environment [ RasMol ]

	Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 1t1f)

Biological Units
	Complete Structure
		Biological Unit 1	[ Jena3D ]
		Biological Unit 2	[ Jena3D ]
		Biological Unit 3	[ Jena3D ]

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ Asym. Unit PNG format \| Asym. Unit - sites PNG format \| Biol. Unit 1 PNG format \| Biol. Unit 1 - sites PNG format \| Biol. Unit 2 PNG format \| Biol. Unit 3 PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	1t1f
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	ANT3_HUMAN \| P01008
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	(no 'Enzyme Classificator' available)
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	613118
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	ANT3_HUMAN \| P01008
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

(no "Related Entries Specified in the PDB File" available for 1T1F)

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (4, 45)

Sites (39, 39)

SS Bonds (12, 12)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (86, 258)

PROSITE Motifs (1, 3)

Exons (6, 18)

Sequences/Alignments

Classification and Annotation

SCOP Domains (1, 3)

CATH Domains (2, 6)

Pfam Domains (1, 3)

Gene Ontology (17, 17)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File